🇺🇸 Amoxicillin-Metronidazole Bismuth quadruple therapy in United States

Amoxicillin-Metronidazole Bismuth quadruple therapy (Amoxicillin-Metronidazole Bismuth quadruple therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Amoxicillin-Metronidazole Bismuth quadruple therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Amoxicillin-Metronidazole Bismuth quadruple therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Amoxicillin-Metronidazole Bismuth quadruple therapy in United States?

National Taiwan University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.